How to Buy Delcath Systems Stock
Delcath Systems Inc
Delcath Systems, Inc. , an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.
Delcath Systems stock last closed at $14.26, up 2.15% from the previous day, and has increased 206.01% in one year. It has overperformed other stocks in the Medical Devices industry by 2.22 percentage points. Delcath Systems stock is currently +234.74% from its 52-week low of $4.26, and -15.97% from its 52-week high of $16.97.
There are currently 33.4M shares of DCTH outstanding. The market capitalization of DCTH is $476.33M. In the past 24 hours, 427,617 DCTH shares were traded.
How to Buy Delcath Systems Stock
Wondering how to invest in Delcath Systems stock? Here's how.
- Figure out where to buy Delcath Systems stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you decide where to buy Delcath Systems stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your brokerage account: Pick your payment method and add your details.
- Analyze Delcath Systems stock: The Delcath Systems ticker symbol is DCTH. Is Delcath Systems stock a good investment? Should you buy shares of DCTH? How do DCTH's underlying business fundamentals look? Do top analysts think Delcath Systems is a good buy? Why has DCTH's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if DCTH is a good stock to buy).
- Make your DCTH buy order: Decide if you will purchase DCTH shares at the current market price or use a limit order to buy DCTH stock at a specific price.
- Get the latest scoop on your investment in DCTH: Create a watchlist to key updates about your new investment in Delcath Systems shares.
Step 1: Figure out where to buy Delcath Systems stock
You will need an online brokerage account to access the NASDAQ market and buy DCTH stock.
Our recommended brokerage: eToro
We believe that eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world financial markets: From Technology to Energy, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen your brokerage, it's time to fill out some personal details so you can buy DCTH today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to create your new trading account.
- Send your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have finished signing up on the best free stock trading app, you need to deposit funds:
Watch the video below if you need help transferring money into your new investment account.
Step 4: Analyze Delcath Systems stock
After you have figured out the best place to buy Delcath Systems stock, it's very important to research their stock before you buy, so you truly wrap your head around the risk as well as the opportunity.
Delcath Systems quick stats
Fundamentals of Delcath Systems
WallStreetZen was created to help everyday investors do better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on DCTH's stock page.
What is the fair value of DCTH stock?
Investors use many financial metrics, analyses, models, and charts to gauge DCTH's intrinsic value.
Using relative valuations methods:
- DCTH could be overvalued based on its P/B ratio of 6.93x, relative to Medical Devices industry P/B ratio of 3.97x
You can do additional valuation analysis on DCTH's stock here.
DCTH Financial Summary
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the DCTH balance sheet.
- Total DCTH debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the DCTH balance sheet.
- DCTH has cash burn of 19240000. It has enough cash and short-term investments to cover this for at least one year.
- DCTH has $53.23M in cash and short term investments. This is sufficient to cover its annual cash burn of $19.24M.
- DCTH has a low debt to equity ratio of 0.11.
Negative Health Checks:
- DCTH profit margin has gone up by 22.38 percentage points in the past year, but the company is still unprofitable.
Do analysts think it's a good time to buy DCTH stock
Out of 3 Equities analysts who research DCTH, the consensus analyst rating on Delcath Systems is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Delcath Systems stock forecast page.
DCTH Technicals
DCTH Earnings
Last year, DCTH revenue was $37.21M. In the last 5 year, DCTH's revenue has increased by 88.1% per year. This was faster than the Medical Devices industry average of 10.31%.
Dig into DCTH's earnings and revenue performance here.
What are DCTH executives and large shareholders up to?
In the last 12 months, executives and large shareholders at DCTH have bought more shares than they have sold.
Gil Aharon, Director of DCTH, was the latest DCTH insider to buy. They bought $2,500,000.00 worth of DCTH stock on Dec 24, 2024.
Learn more about who owns DCTH stock here.
Does DCTH provide a stable income stream?
No, Delcath Systems doesn't provide an income stream by paying out dividends.
What others are saying about DCTH
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Make your DCTH buy order
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually fine. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific dollar amount limit, use a limit order.
Press the Open Trade button and your broker will execute the order.
If you need additional assistance investing in stocks on eToro, click the how to video below:
Step 6: Get the latest scoop on your investment in DCTH
Now that you own some DCTH stock, you'll want to keep up with your new investment.
Start a watchlist to track the most important metrics related to your DCTH stock.
DCTH Feed
How to Buy Stock in Delcath Systems
To summarize, here are the 6 steps to buy stock in Delcath Systems:
- Figure out where to buy Delcath Systems stock
- Sign up for your brokerage account
- Fund your brokerage account
- Analyze Delcath Systems stock
- Make your DCTH buy order
- Get the latest scoop on your investment in DCTH
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get updates on your investment in Delcath Systems, click below.
Trending Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.